FAC is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of FAC shares has increased $0.11 since the market last closed. This is a 2.52% ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund 6.56M Jun 30, 2026 1.22% 27,801,076 ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.

At close: October 29 at 4:00:00 p.m. EDT ...